The Cooper Companies, Inc. which can be found using ticker (COO) now have 12 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between 440 and 345 with the average target price sitting at $408.83. Now with the previous closing price of $389.82 and the analysts are correct then there would likely be a percentage uptick in value of 4.9%. There is a 50 day moving average of $376.81 while the 200 day moving average is $347.87. The total market capitalization for the company now stands at 19.25B. The stock price is currently at: 388.79 USD
The potential market cap would be $20,186,835,629 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 67.15, revenue per share of 69.52 and a 2.62% return on assets.
The Cooper Companies, Inc. is a global medical device company. The Company operates through two segments: CooperVision and CooperSurgical. CooperVision segment is engaged in developing, manufacturing and marketing a range of products for contact lens wearers, featuring advanced materials and optics. CooperVision segment designs its products to solve vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigue, with a broad collection of spherical, toric and multifocal contact lenses. CooperSurgical segment focus on advancing the health of women, babies and families through a diversified portfolio of products and services focusing on women’s health and fertility. CooperSurgical segment supplies the family health care market with a diversified portfolio of products and services. Its office and surgical offerings include products that facilitate surgical and non-surgical procedures that are commonly performed primarily by obstetricians and gynecologists.
